Presentation of encouraging preclinical results for CER-1236 in ovarian cancer, indicating potential effectiveness of the treatment. No observed toxicity in animal models after treatment, highlighting ...
Eterna Therapeutics announced promising preclinical results for its lead cell therapy, ERNA-101, aimed at treating ovarian cancer by activating the immune system. In a study conducted at MD Anderson, ...
Verastem Oncology Announces Publication of the Primary Results from the Phase 2 RAMP 201 Trial of Avutometinib in Combination with Defactinib in Patients with Recurrent Low-Grade Serous Ovarian Cancer ...
Sportschosun on MSN
The difficulty of ovarian cancer surgery can be predicted through vaginal ultrasound...Expect low-co...
A study found that the difficulty of surgery and the degree of cancer spread in the abdominal cavity can be predicted only by ...
News Medical on MSN
Blood test offers hope for more effective ovarian cancer treatment: Study
More than 300,000 women are diagnosed with ovarian cancer globally each year. The four-year clinical trial across 15 Australian hospitals – known as SOLACE2 – was co-led by the University ...
Dr Kathleen Moore from the University of Oklahoma Health Sciences Center reviews key ovarian cancer abstracts from ESGO 2025. She first highlights a multicenter study comparing three vs six cycles of ...
DEAR MAYO CLINIC: I've heard that ovarian cancer is hard to detect. Can you tell me more about the symptoms and if there are any screenings? ANSWER: Ovarian cancer is relatively rare. However, it's ...
Robust objective response rates were observed (31% overall, 44% in KRAS-mutant, and 17% in KRAS wild-type) in patients whose cancer had progressed after multiple prior lines of therapy The majority of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback